Histopathology of pembrolizumab-induced hepatitis: a case report

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text

Medicine, Clinical Sciences, Oncology +12

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

Ayako Suzuki, Elizabeth M. Brunt, David E. Kleiner et al. · Hepatology · 2011 · 336 citations · Full text

Medicine, Pathology, Hepatology +16

Ipilimumab associated hepatitis: imaging and clinicopathologic findings

Kyung Won Kim, Nikhil H. Ramaiya, Katherine M. Krajewski et al. · Investigational New Drugs · 2013 · 233 citations

Medicine, Immunology, Pathology +12